ClinicalTrials.Veeva

Menu

Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

U

University of Regensburg (UR)

Status

Enrolling

Conditions

Peritoneal Carcinomatosis

Study type

Observational

Funder types

Other

Identifiers

NCT04108936
15-101-0357

Details and patient eligibility

About

Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses

Full description

Cross-sectional and longitudinal analysis of cellular immune responses in the context of disease outcome.

Cross-sectional and longitudinal analysis of the microbiome in the context of disease outcome.

Analysis of renal function with respect of different HIPEC regimens

Identification of clinical surrogate parameters for outcome.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • suspicious peritoneal carcinomatosis

Exclusion criteria

  • <18 years

Trial design

250 participants in 2 patient groups

Peritoneal Carcinomatosis
Description:
Patients suffering from Peritoneal carcinomatoses from either CRC, gastric cancer or primary peritoneal malignancies
Control group
Description:
Patients suffering from CRC or gastric cancer without peritoneal carcinomatosis

Trial contacts and locations

2

Loading...

Central trial contact

Jens M Werner, MD; Monika Diehl-Bein

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems